Enzymatic bioassay for therapeutic drug monitoring of HIV protease inhibitors

被引：0
|
作者：
Gulnik, S
Yu, B
Markowitz, M
Erickson, JW
机构：
[1] Sequoia Pharmaceut, Frederick, MD USA
[2] Aaron Diamond AIDS Res Ctr, New York, NY USA
来源：
ANTIVIRAL THERAPY | 2002年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
94
引用
收藏
页码：S103 / S103
页数：1
相关论文
共 50 条
  • [21] SYNTHESIS AND ENZYMATIC STUDIES OF HIV-1 PROTEASE INHIBITORS
    EZZITOUNI, A
    DOLEJAN, D
    OCHIETTI, B
    LETTRE, J
    YELLE, J
    SAUVE, G
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 38 - MEDI
  • [22] RATIONAL DRUG DESIGN - INHIBITORS OF RENIN AND HIV PROTEASE
    TURNER, SR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 204 : 126 - ORGN
  • [23] Rapid enzymatic test for phenotypic HIV protease drug resistance
    Hoffmann, D
    Assfalg-Machleidt, I
    Nitschko, H
    von der Helm, K
    Koszinowski, U
    Machleidt, W
    BIOLOGICAL CHEMISTRY, 2003, 384 (07) : 1109 - 1117
  • [24] HIV-1 protease inhibitors and drug interactions
    Welch, S
    ADDICTION, 1997, 92 (07) : 905 - 905
  • [25] Benefit of therapeutic drug monitoring of protease inhibitors in HIV-infected patients depends on PI used in HAART regimen - ANRS 111 trial
    Duval, Xavier
    Mentre, France
    Rey, Elisabeth
    Auleley, Solange
    Peytavin, Gilles
    Biour, Michel
    Metro, Annie
    Goujard, Cecile
    Taburet, Anne-Marie
    Lascoux, Cecile
    Panhard, Xaviere
    Treluyer, Jean-Marc
    Salmon-Ceron, Dominique
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 (04) : 491 - 500
  • [26] A cell-free enzymatic activity assay for the evaluation of HIV-1 drug resistance to protease inhibitors
    Matsunaga, Satoko
    Masaoka, Takashi
    Sawasaki, Tatsuya
    Morishita, Ryo
    Iwatani, Yasumasa
    Tatsumi, Masashi
    Endo, Yaeta
    Yamamoto, Naoki
    Sugiura, Wataru
    Ryo, Akihide
    FRONTIERS IN MICROBIOLOGY, 2015, 6
  • [27] Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology
    van der Kleij, Maud B. A.
    Guchelaar, Niels A. D.
    Mathijssen, Ron H. J.
    Versluis, Jurjen
    Huitema, Alwin D. R.
    Koolen, Stijn L. W.
    Steeghs, Neeltje
    CLINICAL PHARMACOKINETICS, 2023, 62 (10) : 1333 - 1364
  • [28] Therapeutic drug monitoring and tyrosine kinase inhibitors
    Herviou, Pauline
    Thivat, Emilie
    Richard, Damien
    Roche, Lucie
    Dohou, Joyce
    Pouget, Melanie
    Eschalier, Alain
    Durando, Xavier
    Authier, Nicolas
    ONCOLOGY LETTERS, 2016, 12 (02) : 1223 - 1232
  • [29] Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology
    Maud B. A. van der Kleij
    Niels A. D. Guchelaar
    Ron H. J. Mathijssen
    Jurjen Versluis
    Alwin D. R. Huitema
    Stijn L. W. Koolen
    Neeltje Steeghs
    Clinical Pharmacokinetics, 2023, 62 : 1333 - 1364
  • [30] Optimization of the therapeutic range for therapeutic drug monitoring of posaconazole and isavuconazole using a bioassay approach
    Willeman, T.
    Tonini, J.
    Garnaud, C.
    Bailly, S.
    Gandia, P.
    Stanke-Labesque, F.
    Maubon, D.
    Gautier-Veyret, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 24 - 24
12345